FIRM FIXED PRICENO SET ASIDE USED.
NOVOGENE CORPORATION INC - HUMAN WHOLE GENOME BISULFITE SEQUENCING
PIID: 75N95D21P00120
Signed Date: Feb 25, 2026Effective Date: Aug 18, 2021End Date: Closed on Oct 22, 2021
Key Details
Description
HUMAN WHOLE GENOME BISULFITE SEQUENCING
Contractor Information
Similar Awards
INNOVATION FUNNEL FOR COVID-19 - VALIDATION CENTER
EMORY UNIVERSITY
$41.2M
NHLBI TRANS-OMICS FOR PRECISION MEDICINE (TOPMED) FOR THE CENTRALIZED OMICS RESOURCE (CORE) - RNA-SEQ - 2024 TASK ORDER
NEW YORK GENOME CENTER, INC.
$5.7M
COMMON FUND REPLICATION TO ENHANCE RESEARCH IMPACT INITIATIVE ("REPLICATION INITIATIVE") - VALIDATION CENTER
EMORY UNIVERSITY
$4.0M
COMMON FUND REPLICATION TO ENHANCE RESEARCH IMPACT INITIATIVE ("REPLICATION INITIATIVE") - VALIDATION CENTER
EMORY UNIVERSITY
$4.0M
SCIENTIFIC AND TECHNICAL SUPPORT FOR DCLSR
ASRT, INC.
$3.0M
Stay Updated
Get notified about new opportunities matching your interests.